Tumor immune market add two more fire!

Source: bioprospecting On May 11, 2015, Forbes recently announced 2015 Global 2000, the top 2000 global enterprises This year, the companies on the Global 2000 list come from 61 countries and regions, with a total revenue of US $39 trillion, a total profit of US $3 trillion, a total asset value of US $162 trillion and a total market value of US $48 trillion The Global 2000 list is a very comprehensive list, including the largest and most powerful listed companies in the world according to the four indicators of revenue, profit, assets and market value In this year's list, companies in the United States and China have won the top 10 places for the second year in a row, and industrial and Commercial Bank of China has won the championship for the third year in a row In the pharmaceutical sector, Johnson & Johnson, ranked 34th on the list, was the first to come into view, up seven places from last year In 2014, sales reached US $74.2 billion, net profit US $16.3 billion, assets US $131.1 billion and market value US $275.7 billion It is understood that the sales of 74.2 billion Chinese pharmaceutical sector contributed 32.4 billion US dollars, up 15% year on year As we all know, Johnson & Johnson is not only involved in the pharmaceutical industry, so who ranks first in the "pure blood" pharmaceutical industry? The answer is Pfizer Pfizer ranked 48th in 2015 Global 2000, down three places from last year In 2014, sales reached US $49.6 billion, net profit US $9.1 billion, assets US $169.3 billion and market value US $21.7 billion In the form of table below, we list the top 20 pharmaceutical giants in 2015 Global 2000 except Johnson & Johnson: data sources: Notes on Forbes Chinese website: Merck & CO (Merck & Co, the region outside the United States and Canada is called Merck); Merck in Germany